Pacific Biomarkers - Ownership and Business Overview

Life ScienceCompany

Pacific Biomarkers Ownership

Who owns Pacific Biomarkers?

Pacific Biomarkers is owned by Nexelis. It was acquired on November 19, 2018.

Pacific Biomarkers Business Overview

Where is Pacific Biomarkers headquartered?

Pacific Biomarkers is headquartered in Seattle, Washington.

What sector is Pacific Biomarkers in?

Pacific Biomarkers is a life science company.

When was Pacific Biomarkers founded?

Pacific Biomarkers was founded in 1989.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.

Pacific Biomarkers

645 Elliott Ave W, Suite 300,
Seattle, Washington 98119
United States,
(206) 298-0068
www.pacbio.com

Pacific Biomarkers provides specialty biomarker development and central laboratory testing services for the pharmaceutical and biotech markets. The company is a full-service bioanalytical laboratory, capable of supporting pharma sponsors with efficacy and drug safety-related testing from preclinical through Phase IV clinical studies.


 Subscribe to unlock this and 201,888
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.